182886-36-8Relevant academic research and scientific papers
Vasopeptidase inhibitors: Incorporation of geminal and spirocyclic substituted azepinones in mercaptoacyl dipeptides
Robl, Jeffrey A.,Sulsky, Richard,Sieber-McMaster, Ellen,Ryono, Denis E.,Cimarusti, Maria P.,Simpkins, Ligaya M.,Karanewsky, Donald S.,Chao, Sam,Asaad, Magdi M.,Seymour, Andrea A.,Fox, Maxine,Smith, Patricia L.,Trippodo, Nick C.
, p. 305 - 311 (1999)
A series of 7-(di)alkyl and spirocyclic substituted azepinones were generated and incorporated as conformationally restricted dipeptide surrogates in mercaptoacyl dipeptides. Clear structure-activity relationships with respect to both angiotensin-converti
N-formyl hydroxylamine containing compounds useful as ACE inhibitors and/or NEP inhibitors
-
Page column 21; 22, (2010/02/08)
N-formyl hydroxylamines are provided which have the structure wherein R is H, alkyl, alkenyl, aryl-(CH2)p—, heteroaryl-(CH2)p— or cycloheteroalkyl-(CH2)p— R1is H or COR2where R2is alkyl, aryl-(CH2)p—, cycloheteroalkyl-(CH2)p—, heteroaryl-(CH2)p—, alkoxy or cycloalkyl-(CH2)p—, p is 0 to 8, and A is a dipeptide derived from an amino acid or is a conformationally restricted dipeptide mimic. The above compounds are useful in treating hypertension congestive heart failure, renal failure, and hepatic cirrhosis.
